Volume 10, Number 10—October 2004
Perspective
West Nile Virus Economic Impact, Louisiana, 2002
Table 1
Treatment/Service category | nb | Per patient costs ($) |
|||
---|---|---|---|---|---|
Median | Range | Interquartile range | Total costs ($) | ||
Pharmacy/Medical supplies | 115 | 2,934 | 16–88,825 | 994–7,601 | 887,759 |
Diagnostic | 118 | 2,417 | 95–42,064 | 1,370–4,844 | 547,935 |
Room and board | 117 | 1,132 | 52–16,445 | 640–2,266 | 237,917 |
Medical/Surgical services | 75 | 675 | 15–21,606 | 183–3,261 | 200,233 |
Intensive care | 24 | 5,526 | 439–17,769 | 2,320–11,001 | 162,360 |
Rehabilitationc | 35 | 425 | 71–4,202 | 189–367 | 32,947 |
Emergency service | 79 | 271 | 90–1,416 | 195–372 | 25,947 |
Other | 33 | 109 | 1–2,620 | 20–247 | 8,873 |
Total | 119 | 8,274 | 623–164,668 | 3,627–18,197 | 2,103,971 |
aEconomic costs were estimated on the basis of hospital charges, by using Medicare cost-to-charge ratio for Louisiana—0.41 for urban areas and 0.488 for rural areas.
bn, number of patients who incurred costs in this category among the 119 patients. Per patient statistics include only the patients who incurred costs in this category.
cRehabilitation costs indicated are those incurred during acute care hospital treatment. Costs of rehabilitation treatment in rehabilitation facilities are not included.
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.